Wilkinson VL - Search Results

1

Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo.

Gately MK, Carvajal DM, Connaughton SE, Gillessen S, Warrier RR, Kolinsky KD, Wilkinson VL, Dwyer CM, Higgins GF Jr, Podlaski FJ, Faherty DA, Familletti PC, Stern AS, Presky DH. Gately MK, et al. Among authors: wilkinson vl. Ann N Y Acad Sci. 1996 Oct 31;795:1-12. doi: 10.1111/j.1749-6632.1996.tb52650.x. Ann N Y Acad Sci. 1996. PMID: 8958912

2

Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA.

Wilkinson VL, Warrier RR, Truitt TP, Nunes P, Gately MK, Presky DH. Wilkinson VL, et al. J Immunol Methods. 1996 Jan 16;189(1):15-24. doi: 10.1016/0022-1759(95)00223-5. J Immunol Methods. 1996. PMID: 8576576

3

Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock.

Mattner F, Ozmen L, Podlaski FJ, Wilkinson VL, Presky DH, Gately MK, Alber G. Mattner F, et al. Among authors: wilkinson vl. Infect Immun. 1997 Nov;65(11):4734-7. doi: 10.1128/iai.65.11.4734-4737.1997. Infect Immun. 1997. PMID: 9353058 Free PMC article.

4

Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.

Presky DH, Minetti LJ, Gillessen S, Wilkinson VL, Wu CY, Gubler U, Chizzonite R, Gately MK. Presky DH, et al. Among authors: wilkinson vl. J Immunol. 1998 Mar 1;160(5):2174-9. J Immunol. 1998. PMID: 9498755

5

Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits.

Wang X, Wilkinson VL, Podlaski FJ, Wu C, Stern AS, Presky DH, Magram J. Wang X, et al. Among authors: wilkinson vl. Eur J Immunol. 1999 Jun;29(6):2007-13. doi: 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0. Eur J Immunol. 1999. PMID: 10382764 Free article.

6

Cloning and characterization of a mouse IL-12 receptor-beta component.

Chua AO, Wilkinson VL, Presky DH, Gubler U. Chua AO, et al. Among authors: wilkinson vl. J Immunol. 1995 Nov 1;155(9):4286-94. J Immunol. 1995. PMID: 7594587

7

Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.

Rakhit A, Yeon MM, Ferrante J, Fettner S, Nadeau R, Motzer R, Bukowski R, Carvajal DM, Wilkinson VL, Presky DH, Magram J, Gately MK. Rakhit A, et al. Among authors: wilkinson vl. Clin Pharmacol Ther. 1999 Jun;65(6):615-29. doi: 10.1016/S0009-9236(99)90083-8. Clin Pharmacol Ther. 1999. PMID: 10391667 Clinical Trial.

8

Association of the human Fc epsilon RI gamma subunit with novel cell surface polypeptides.

Schöneich JT, Wilkinson VL, Kado-Fong H, Presky DH, Kochan JP. Schöneich JT, et al. Among authors: wilkinson vl. J Immunol. 1992 Apr 1;148(7):2181-5. J Immunol. 1992. PMID: 1532003

9

Consensus repeat domains of E-selectin enhance ligand binding.

Li SH, Burns DK, Rumberger JM, Presky DH, Wilkinson VL, Anostario M Jr, Wolitzky BA, Norton CR, Familletti PC, Kim KJ, et al. Li SH, et al. Among authors: wilkinson vl. J Biol Chem. 1994 Feb 11;269(6):4431-7. J Biol Chem. 1994. PMID: 7508442 Free article.

10

Production of monoclonal antibodies to prostromelysin (ProMMP-3) and establishment of a quantitative prostromelysin ELISA assay.

Presky DH, Wilkinson VL, Flannery MD, Korkmaz E, Walsky R, Mondini-Minetti LJ, Fotouhi N, Levin W. Presky DH, et al. Among authors: wilkinson vl. Biochem Biophys Res Commun. 1993 May 28;193(1):364-70. doi: 10.1006/bbrc.1993.1632. Biochem Biophys Res Commun. 1993. PMID: 8503927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters